When a company such as OGXI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the OGXI split history from start to finish, an original position size of 1000 shares would have turned into 55.5555555555556 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OGXI shares, starting with a $10,000 purchase of OGXI, presented on a split-history-adjusted basis factoring in the complete OGXI split history.

About OGXI

OncoGenex Pharmaceuticals is a biopharmaceutical company that has been focused on the development of cancer therapeutics. Apatorsen is Co.'s product candidate that is designed to inhibit production of Hsp27, a cell-survival protein expressed in various types of cancers including bladder, prostate, breast, pancreatic and non-small cell lung cancer. Hsp27 expression is stress-induced, including by various anti-cancer therapies. Co. has initiated the Ongoing Studies Evaluating Treatment Resistance in CAncer program which encompasses six phase 2 clinical studies designed to evaluate whether treatment with apatorsen can lead to improved prognosis and treatment outcomes for cancer patients. According to our OGXI split history records, OGXI has had 1 split.

OGXI Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved